Collaring Wolfe: Propoxyphene Moves Activist Back To Public Supplicant Role

For almost four decades, one of the most painful public relations challenges for drug companies has been the need to respond quickly to surprise petitions from Public Citizen's Health Research Group asking FDA to withdraw a drug for an alleged safety issue